A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy BodiesMichael A. Nalls, John Q. Trojanowski, Fabiana Novellino et al.|JAMA Neurology|2013Cited by 444
Progression of Parkinson's disease in the clinical phase: potential markersWalter Maetzler, Daniela Berg, Inga Liepelt|The Lancet Neurology|2009Cited by 304
<i>GBA</i> ‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal studyKathrin Brockmann, Daniela Berg, Karin Srulijes et al.|Movement Disorders|2014Cited by 271
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodiesJosé Brás, John Hardy, Rita Guerreiro et al.|Human Molecular Genetics|2014Cited by 241
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot StudyMichelle M. Mielke, Inga Liepelt‐Scarfone, Walter Maetzler et al.|PLoS ONE|2013Cited by 238